ABT
47
-3
WBA
22
-5
EMR
37
-5
MO
60
-2
MMM
37
5
GS
75
-4
GPC
54
-7
CRM
44
-5
MTB
49
-3
SE
50
-7
CAT
62
-4
EBAY
48
-5
EMN
69
-4
AMT
42
-5
ICE
50
-3
UPS
48
-2
STI
32
-26
TSN
34
-2
TDC
67
-8
DG
28
4
ABT
47
-3
WBA
22
-5
EMR
37
-5
MO
60
-2
MMM
37
5
GS
75
-4
GPC
54
-7
CRM
44
-5
MTB
49
-3
SE
50
-7
CAT
62
-4
EBAY
48
-5
EMN
69
-4
AMT
42
-5
ICE
50
-3
UPS
48
-2
STI
32
-26
TSN
34
-2
TDC
67
-8
DG
28
4
Financhill
Back

Plus Therapeutics Quote, Financials, Valuation and Earnings

I love this overnight trade happening Thursday

Access my free presentation on these overnight trades right here
Sell
38

PSTV
Plus Therapeutics

Last Price:
1.74
Seasonality Move:
107.82%

7 Day Trial

ALL ACCESS PASS

$ 7

The little-known AI stock you need to read about now...

Get the name - FREE.

Plus Therapeutics Price Quote

$1.74
+0.02 (+-0.03%)
(Updated: May 2, 2024 at 3:50 AM ET)

Plus Therapeutics Key Stats

Sell
38
Plus Therapeutics (PSTV) is a Sell
Day range:
$1.71 - $1.78
52-week range:
$0.97 - $5.09
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.86
P/B ratio:
0%
Volume:
5K
Avg. volume:
23.2K
1-year change:
-56.89%
Market cap:
$7.5M
Revenue:
$0
EPS:
$-4.39

How Much Does Plus Therapeutics Make?

Data Unavailable

Is Plus Therapeutics Growing As A Company?

Data Unavailable

Plus Therapeutics Stock Price Performance

  • Did Plus Therapeutics Stock Go Up Last Month?
    Plus Therapeutics share price went down by -4.44% last month
  • Did PSTV's Share Price Rise Over The Last Year?
    PSTV share price fell by -56.89% over the past 1 year

What Is Plus Therapeutics 52-Week High & Low?

Plus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Plus Therapeutics?

  • How Much Debt Does Plus Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Plus Therapeutics Have?
    Cash and short term investments quarterly total is $8.6M
  • What Is Plus Therapeutics’s Book Value Per Share?
    Book value per share is -0.30

Is Plus Therapeutics Cash Flow Positive?

  • What Is PSTV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$12.9M
  • What Is Plus Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.4M
  • What Is Plus Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$160K

Plus Therapeutics Return On Invested Capital

Data Unavailable

Plus Therapeutics Earnings Date & Stock Price

Plus Therapeutics Competitors

  • Who Are Plus Therapeutics's Competitors?
    Below is a list of companies who compete with Plus Therapeutics or are related in some way:
    • Asensus Surgical Inc (ASXC)
    • Perspective Therapeutics Inc (CATX)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Plus Therapeutics Dividend Yield

Data Unavailable

Plus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 40.34%
Revenue: 0% 54.35%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 16.50
Upside from Last Price: 859.3%

Major Shareholders

  • How many PSTV shares are owned by institutional investors?
    160.5K PSTV shares are owned by institutional investors
  • How many PSTV shares are owned by insiders?
    1.2M PSTV shares are owned by insiders